{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10"],"submitter":["Rahim Khorasani M"],"pubmed_abstract":["<h4>Background</h4>Ceftolozane/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a high range of efficacy and broad-spectrum action against multidrug-resistant bacterial strains.<h4>Objectives</h4>The present study aimed to analyze the <i>in vitro</i> activity of Ceftolozane/Tazobactam against extended-spectrum β-lactamases (ESBLs)-producing <i>Escherichia coli</i> (ESBLs-EC) and <i>Klebsiella pneumonia</i> (ESBLs-KP) in the published literature to provide international data on the antimicrobial stewardship programs.<h4>Design</h4>Systematic review and meta-analysis.<h4>Methods</h4>A systematic literature search was conducted on the Web of Science, Embase, PubMed, Scopus, and Google Scholar electronic databases from the beginning of databases to December 2022 to cover all pub"],"journal":["Therapeutic advances in infectious disease"],"pagination":["20499361231212074"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10656798"],"repository":["biostudies-literature"],"pubmed_title":["Global evaluation of the antibacterial activity of Ceftolozane/Tazobactam against ESBLs-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>: a systematic review and meta-analysis."],"pmcid":["PMC10656798"],"pubmed_authors":["Rahim Khorasani M","Rostami S","Sheikhi R","Bakhshi A"],"additional_accession":[]},"is_claimable":false,"name":"Global evaluation of the antibacterial activity of Ceftolozane/Tazobactam against ESBLs-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>: a systematic review and meta-analysis.","description":"<h4>Background</h4>Ceftolozane/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a high range of efficacy and broad-spectrum action against multidrug-resistant bacterial strains.<h4>Objectives</h4>The present study aimed to analyze the <i>in vitro</i> activity of Ceftolozane/Tazobactam against extended-spectrum β-lactamases (ESBLs)-producing <i>Escherichia coli</i> (ESBLs-EC) and <i>Klebsiella pneumonia</i> (ESBLs-KP) in the published literature to provide international data on the antimicrobial stewardship programs.<h4>Design</h4>Systematic review and meta-analysis.<h4>Methods</h4>A systematic literature search was conducted on the Web of Science, Embase, PubMed, Scopus, and Google Scholar electronic databases from the beginning of databases to December 2022 to cover all pub","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan-Dec","modification":"2025-04-21T18:22:14.205Z","creation":"2025-04-05T17:12:08.671Z"},"accession":"S-EPMC10656798","cross_references":{"pubmed":["38029068"],"doi":["10.1177/20499361231212074"]}}